Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
CC transcript
Director departure
Inv. presentation
|
|
Orexigen Therapeutics, Inc. (OREXQ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/04/2012 |
PRN
| Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences |
| 07/09/2012 |
PRN
| Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference |
| 06/06/2012 |
PRN
| Orexigen® Therapeutics and Sharecare® Announce Partnership for WeightMate™, a Comprehensive Weight Management Program |
| 05/31/2012 |
PRN
| Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference |
| 04/27/2012 |
PRN
| Lota S. Zoth Joins Orexigen Therapeutics Board of Directors |
| 02/06/2012 |
PRN
| Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment for the Contrave® Outcomes Trial |
| 12/22/2011 |
PRN
| Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock |
| 12/14/2011 |
PRN
| Orexigen® Therapeutics Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock |
| 10/03/2011 |
PRN
| Orexigen® Therapeutics Presents Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society |
| 06/01/2011 |
PRN
| Orexigen® Therapeutics Schedules June 3, 2011 Webcast and Conference Call to Provide a Regulatory Update on Contrave® NDA |
| 05/02/2011 |
PRN
| Orexigen® Therapeutics Schedules May 9, 2011 Webcast Discussion of Financial Results for the First Quarter Ended March 31, 2011 |
| 04/26/2011 |
PRN
| Orexigen® Therapeutics Announces Upcoming Data Presentations at The American College of Obstetricians and Gynecologists Annual Clinical Meeting |
| 04/04/2011 |
PRN
| Orexigen?? Therapeutics Presents Additional Contrave® Data from Phase 3 COR-II Trial on 24-Hour Ambulatory Blood Pressure Monitoring |
| 03/29/2011 |
PRN
| Orexigen® Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting |
| 03/10/2011 |
PRN
| Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results |
| 03/10/2011 |
PRN
| Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results |
| 03/03/2011 |
PRN
| Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010 |
| 02/17/2011 |
PRN
| Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer |
| 02/09/2011 |
PRN
| Orexigen® Therapeutics Announces Corporate Realignment |
| 07/29/2010 |
PRN
| Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet |
| 06/26/2010 |
PRN
| Orexigen(R) Therapeutics Announces That Contrave(R) Reduced Depression Scores and Body Weight in Overweight and Obese Patients With Major Depression |
| 06/25/2010 |
PRN
| Orexigen(R) Therapeutics Presents New Data Showing Contrave(R) Significantly Lowers Weight, Improves Blood Glucose Control in Obese Patients With Type 2 Diabetes |
| 06/25/2010 |
PRN
| Orexigen(R) Therapeutics Presents New Data Showing Contrave(R) Significantly Lowers Weight, Improves Blood Glucose Control in Obese Patients With Type 2 Diabetes |
| 06/21/2010 |
PRN
| Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association Annual Scientific Meeting |
|
|